BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:38 PM
 | 
Feb 05, 2010
 |  BC Extra  |  Clinical News

Study compares Avastin with Lucentis

Researchers from Kaiser Permanente Southern California published in Ophthalmology a retrospective analysis from a registry comparing Avastin bevacizumab vs. Lucentis ranibizumab in treatment-naive patients with age-related macular degeneration. In the study, 27.3% of Avastin patients had improved vision compared with 20.2% of those in the Lucentis group (p=0.2). Improvement...

Read the full 240 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >